Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Waverley Pharma Inc V.WAVE

Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. Its primary focus is the PARP-1 program and secondary focus is the generic oncology injectable market in European Union, the United Kingdom (UK) and North America. It has entered into a license, manufacture, supply, marketing and distribution agreement with Reliance Life Sciences Private Limited, which has granted it an exclusive territorial license to market and sell capecitabine in the UK and Germany as well as a non-exclusive territorial license to market and sell temozolomide and erlotinib in the UK. Its generic oncology products include bortezomib and pemetrexed. Bortezomib is an injectable generic chemotherapy drug, developed for the treatment of multiple myeloma and mantle cell lymphoma. Pemetrexed is an injectable generic chemotherapy drug, developed for the treatment of non-small cell lung cancer and pleural mesothelioma.


TSXV:WAVE - Post by User

Comment by AGResearchon Aug 25, 2020 10:32pm
218 Views
Post# 31453535

RE:Cup and Handle Breakout!

RE:Cup and Handle Breakout!Just wanted to remind everyone, that I called the breakout correctly here with all the bashing going on near recent lows :).

My assessment has changed somewhat since the financials release yesterday. They were not impressive, with revenues falling by $120K though other expenses also fell by the same amount. Cash is down to $500K from $1M. There is a chance that they'll do a raise in the near future if the revenues don't pick up again.

To that effect, today's NR was good and hopefully it leads to tangible sales/contracts.

Full disclosure: I took profits at .23 - .24 from .18 avg. Keep that in mind when reading my further analysis/opinion.

Current major resistance area is at .24 - .25. The reason today's NR failed to generate enough excitement to break through it is because there were no sales or numbers attached to it. If they can produce them in the nearterm, it will break through no doubt. Current market cap is still relatively cheap.

There is a gap at .205 which I believe will fill in the coming days. Previous strong resistance at .19 - .20 is strong support now and I expect it to hold unless there is a significant delay before next news release.

Could it break through .24 - .25 without a catalyst? It's possible. Shorts summary report from a couple of days ago shows 1.3M short position. If they did not cover, it could result in a short squeeze and a spike in sp. COVID-19 treatment development update is another wildcard.

My decision to sell was driven partially by technicals (Accum/Dist showing liquidation/selling pressure), iced .24 ask and worse financial results that I had hoped for. I will keep WAVE on my watch list and hope that they can deliver some good numbers next quarter or make progress with their COVID-19 treatment development. I may re-enter then.

Best of luck to everyone. Hopefully, you've already made some profits here from recent lows and will see further appreciation from current levels. Cheers!

AGResearch wrote: This is an explosive chart, ladies and gentlemen! Add to the fact that 1.2M shorts will have to cover and only 13M shares are tradeable. Oh, and you can still get in at over 50% discount to what it cost the insiders holding 75% of the float (.50)!! It's going to be a very nice week coming up!

https://twitter.com/agstockpicks/status/1296899160294162440?s=20


<< Previous
Bullboard Posts
Next >>